![Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study - ScienceDirect Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002927003019300-gr1.gif)
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study - ScienceDirect
Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens | PLOS ONE
![PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | Semantic Scholar PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/84ceac78ff0a41f05434a2950562c2d730ba5663/3-Table1-1.png)
PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | Semantic Scholar
![PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis by Ri-Nan, Zheng · 3143460218 · OA.mg PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis by Ri-Nan, Zheng · 3143460218 · OA.mg](https://og.oa.mg/Comparative%20study%20of%20omeprazole%2C%20lansoprazole%2C%20pantoprazole%20and%20esomeprazole%20for%20symptom%20relief%20in%20patients%20with%20reflux%20esophagitis.png?author=%20Ri-Nan,%20Zheng)
PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis by Ri-Nan, Zheng · 3143460218 · OA.mg
![The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/39/11/2020/F1.large.jpg)
The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition
MedRewind - PPIs like omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole, or dexlansoprazole. | Facebook
![Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-39335-7/MediaObjects/41598_2019_39335_Fig5_HTML.png)
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports
![Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors - Philip Katz, Peter J. Kahrilas, David A. Johnson, Tore Lind, Kerstin Röhss, Barry Traxler, Vincent Hugo, Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors - Philip Katz, Peter J. Kahrilas, David A. Johnson, Tore Lind, Kerstin Röhss, Barry Traxler, Vincent Hugo,](https://journals.sagepub.com/cms/10.1177/1756283X15592583/asset/images/large/10.1177_1756283x15592583-fig2.jpeg)
Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors - Philip Katz, Peter J. Kahrilas, David A. Johnson, Tore Lind, Kerstin Röhss, Barry Traxler, Vincent Hugo,
![Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis](https://f6publishing.blob.core.windows.net/f829b072-b1f2-4453-86e0-04696d6b2a1f/WJG-15-990-g001.jpg)